FDA Inspection
AstraZeneca UK Ltd.AstraZeneca UK Ltd. – FDA Inspection, Sep 22, 2017
Record Details
This FDA Inspection record concerns AstraZeneca UK Ltd., with an inspection on September 22, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 6fad3859-eec2-4184-9e0c-a44c332e56f7
Inspection Facts
- Inspection number
- 1030226
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AstraZeneca UK Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 16, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca UK Ltd.
- FDA Inspection 1274179 - 2023-04-27
- FDA Inspection 1129231 - 2020-02-23
- FDA Inspection 1017549 - 2017-04-13
- FDA Inspection 878183 - 2014-04-11
- FDA Inspection 785250 - 2012-03-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.